Task: Please answer the following question about the molecule with SMILES c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2.
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Answer: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2
c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2
10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.